⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 207 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 207 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT May 27, 2026

Sitagliptin Sandoz 100 mg – Filmtabletten 100 mg (Filmtablette)

📷 Wikipedia: Sitagliptin · Source
Sitagliptin Sandoz 100 mg – Filmtabletten 100 mg (Filmtablette)
📷 Wikipedia: Sitagliptin · Source
Sitagliptin Sandoz 100 mg film-coated tablets are banned from parallel export due to manufacturing capacity shortages. The affected packs are the 30-tablet box and blister pack, which have been unavailable since 27 May 2026.
⚠️
Shortage ongoing
SITAGLIPTIN HYDROCHLORID MONOHYDRAT is currently in short supply in AT.
📈 Timeline
1 days active so far
May 29, 2026 May 29, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Sitagliptin is a medicine used to lower blood sugar in people with diabetes. It comes as a small tablet you swallow.

What's happening? The packs of this tablet are not available right now. The maker cannot make enough to meet demand.

Does this affect me? If you take this medicine, you may have trouble getting your usual supply in Austria.

What should I do? Ask your pharmacist or doctor for advice about another suitable medicine or supply.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: A10BH01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-05-27]

First published
May 27, 2026
Last refreshed by us
11 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Sitagliptin Sandoz 100 mg – Filmtabletten 100 mg (Filmtablette). Sitagliptin Sandoz 100 mg film-coated tablets are banned from parallel export due to manufacturing capacity shortages. The affected packs are the 30-tablet box and blister pack, which have been unavailable since 27 May 2026.
When was this alert issued?
This alert was issued on May 27, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.